Cancer Gene Therapy - Table of Contents alert Volume 21 Issue 6

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 21, Issue 6 (June 2014) In this issue Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement NOW AVAILABLE: Discounts on lab equipment Savings and information - all in one place! Check Marketplace before you buy Browse LAB OFFERS and PRODUCT FOCUS    Original Articles Top Enhanced expression of the β4-galactosyltransferase 2 gene impairs mammalian tumor growth M Tagawa, K Shirane, L Yu, T Sato, S Furukawa, H Mizuguchi, R Kuji, K Kawamura, N Takahashi, K Kato, S Hayakawa, S Sawada and K Furukawa Cancer Gene Ther 2014 21: 219-227; advance online publication, June 6, 2014; 10.1038/cgt.2014.21 Abstract | Full Text Evaluation of apoptogenic adenovirus type 5 oncolytic vectors in a Syrian hamster head and neck cancer model S Vijayalingam, M Kuppuswamy, T Subramanian, F F Strebeck, C L West, M Varvares and G Chinnadurai Cancer Gene Ther 2014 21: 228-237; advance online publication, May 30, 2014; 10.1038/cgt.2014.22 Abstract | Full Text Akt-mediated transforming growth factor-β1-induced epithelial–mesenchymal transition in cultured human esophageal squamous cancer cells X Xuan, Q Zeng, Y Li, Y Gao, F Wang, H Zhang, Z Wang, H He and S Li Cancer Gene Ther 2014 21: 238-245; advance online publication, May 30, 2014; 10.1038/cgt.2014.23 Abstract | Full Text EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1-integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2 S Sangboonruang, P Thammasit, N Intasai, W Kasinrerk, C Tayapiwatana and K Tragoolpua Cancer Gene Ther 2014 21: 246-255; advance online publication, June 13, 2014; 10.1038/cgt.2014.24 Abstract | Full Text High scFv–receptor affinity does not enhance the antitumor activity of HER2-retargeted measles virus L Suksanpaisan, S J Russell and K-W Peng Cancer Gene Ther 2014 21: 256-260; advance online publication, May 30, 2014; 10.1038/cgt.2014.25 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.